• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肾细胞癌治疗结果及预后因素评估]

[Assessment of treatment outcome and prognostic factors of renal cell cancer].

作者信息

Kanamaru H, Shirahase T, Isogawa Y, Moroi S, Kihara Y, Okuno H, Kuo J Y, Taniguchi T, Arai Y, Tanaka Y

机构信息

Department of Urology, Public Toyooka Hospital.

出版信息

Hinyokika Kiyo. 1994 Jan;40(1):5-8.

PMID:8109474
Abstract

We assessed the treatment outcome of 71 patients (45 men and 26 women) with renal cell cancer treated at the Public Toyooka Hospital from 1969 to 1992. The patient's age varied from 15 to 85 (mean 64). The overall actuarial and disease specific survival rates at 5 years were 55% and 67%, respectively. Statistical analysis of various parameters associated with prognosis was performed. The parameters achieving statistical significance were pT, PV, distant metastasis, grade, histological architecture, cell type, tumor size and erythrocyte sedimentation rate.

摘要

我们评估了1969年至1992年在丰冈市立医院接受治疗的71例肾细胞癌患者(45例男性和26例女性)的治疗结果。患者年龄在15岁至85岁之间(平均64岁)。5年时的总体精算生存率和疾病特异性生存率分别为55%和67%。对与预后相关的各种参数进行了统计分析。具有统计学意义的参数为pT、PV、远处转移、分级、组织学结构、细胞类型、肿瘤大小和红细胞沉降率。

相似文献

1
[Assessment of treatment outcome and prognostic factors of renal cell cancer].[肾细胞癌治疗结果及预后因素评估]
Hinyokika Kiyo. 1994 Jan;40(1):5-8.
2
Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.肾周脂肪浸润和肿瘤大小在肾细胞癌中的预后意义
J Urol. 2008 Aug;180(2):486-91; discussion 491. doi: 10.1016/j.juro.2008.04.034. Epub 2008 Jun 11.
3
Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.微血管肿瘤浸润、肿瘤大小与富尔曼分级:肾细胞癌预后评估的病理三联征
J Urol. 2007 Aug;178(2):425-8; discussion 428. doi: 10.1016/j.juro.2007.03.128. Epub 2007 Jun 11.
4
Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.异时性双侧肾细胞癌:风险评估、预后及无原发瘤间期的相关性
J Urol. 2007 Jun;177(6):2081-6; discussion 2086-7. doi: 10.1016/j.juro.2007.01.122.
5
Impact of clinicopathological parameters in patients treated for renal cell carcinoma.临床病理参数对接受肾细胞癌治疗患者的影响。
J Urol. 2007 May;177(5):1687-91. doi: 10.1016/j.juro.2007.01.065.
6
[Treatment outcome of 288 cases of renal cell carcinoma].
Hinyokika Kiyo. 1996 Jan;42(1):11-6.
7
Outcomes following partial nephrectomy by tumor size.根据肿瘤大小进行部分肾切除术后的结果。
J Urol. 2008 Nov;180(5):1912-7. doi: 10.1016/j.juro.2008.07.047. Epub 2008 Sep 17.
8
Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.基于术前血清C反应蛋白和TNM分类的肾切除术治疗透明细胞肾细胞癌患者新结局预测模型的开发与外部验证:TNM-C评分
J Urol. 2009 Mar;181(3):1004-12; discussion 1012. doi: 10.1016/j.juro.2008.10.156. Epub 2009 Jan 16.
9
Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?年轻和老年患者的散发性肾细胞癌:是否存在不同的临床病理特征和疾病特异性生存率?
World J Surg Oncol. 2007 Feb 5;5:16. doi: 10.1186/1477-7819-5-16.
10
Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.pT3a期透明细胞肾细胞癌中的肾窦脂肪浸润影响无淋巴结受累或远处转移患者的预后。
J Urol. 2009 May;181(5):2027-32. doi: 10.1016/j.juro.2009.01.048. Epub 2009 Mar 14.